Advertisement
Screener

HOOKIPA PHARMA INC. Proceeds from Common Stock Issued

HOOKIPA PHARMA INC. Proceeds from Common Stock Issued

HOOKIPA PHARMA INC. reported Proceeds from Common Stock Issued of $49.04 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-28.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2025-02-28

  • HOOKIPA PHARMA INC. proceeds from issuance of common stock for the quarter ending 2023-12-31 was $21.25M.
  • HOOKIPA PHARMA INC. proceeds from issuance of common stock for the quarter ending 2023-09-30 was -$395.00K, a 19850.00% decline year-over-year.
  • HOOKIPA PHARMA INC. proceeds from issuance of common stock for the quarter ending 2023-06-30 was $28.19M, a 2818700.00% increase year-over-year.
  • HOOKIPA PHARMA INC. proceeds from issuance of common stock for the quarter ending 2023-03-31 was $1.00K, a 100.00% decline year-over-year.
  • HOOKIPA PHARMA INC. proceeds from issuance of common stock for fiscal 2023 was $49.04M, a 7.34% increase from fiscal 2022.
  • HOOKIPA PHARMA INC. proceeds from issuance of common stock for fiscal 2022 was $45.69M, a 22407.88% increase from fiscal 2021.
  • HOOKIPA PHARMA INC. proceeds from issuance of common stock for fiscal 2021 was $203.00K, a 99.52% decline from fiscal 2020.
  • HOOKIPA PHARMA INC. proceeds from issuance of common stock for fiscal 2020 was $42.64M, a 42.97% decline from fiscal 2019.
Period endProceeds from Issuance of Common Stock 3 monthProceeds from Issuance of Common Stock 6 monthProceeds from Issuance of Common Stock 9 monthProceeds from Issuance of Common Stock 12 month
2023-12-31$21.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$20.85M
derived: sum of 2 quarters · filed 2025-02-28
$49.04M
derived: sum of 3 quarters · filed 2025-02-28
$49.04M
10-K · filed 2025-02-28
2023-09-30-$395.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$27.79M
derived: sum of 2 quarters · filed 2024-11-14
$27.79M
10-Q · filed 2024-11-14
$27.79M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30$28.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$28.19M
10-Q · filed 2024-08-08
$28.19M
derived: sum of 3 quarters · filed 2025-02-28
$28.19M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31$1.00K
10-Q · filed 2024-05-09
$1.00K
derived: sum of 2 quarters · filed 2025-02-28
$3.00K
derived: sum of 3 quarters · filed 2025-02-28
$4.00K
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$2.00K
derived: sum of 2 quarters · filed 2025-02-28
$3.00K
derived: sum of 3 quarters · filed 2025-02-28
$45.69M
10-K · filed 2025-02-28
2022-09-30$2.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$3.00K
derived: sum of 2 quarters · filed 2023-11-09
$45.69M
10-Q · filed 2023-11-09
$45.66M
derived: sum of 4 quarters · filed 2024-03-22
2022-06-30$1.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$45.69M
10-Q · filed 2023-08-10
$45.65M
derived: sum of 3 quarters · filed 2024-03-22
$45.66M
derived: sum of 4 quarters · filed 2024-03-22
2022-03-31$45.69M
10-Q · filed 2023-05-11
$45.65M
derived: sum of 2 quarters · filed 2024-03-22
$45.65M
derived: sum of 3 quarters · filed 2024-03-22
$45.77M
derived: sum of 4 quarters · filed 2024-03-22
2021-12-31-$36.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22
-$34.00K
derived: sum of 2 quarters · filed 2024-03-22
$78.00K
derived: sum of 3 quarters · filed 2024-03-22
$203.00K
10-K · filed 2024-03-22
2021-09-30$2.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
$114.00K
derived: sum of 2 quarters · filed 2022-08-11
$239.00K
10-Q · filed 2021-11-10
$42.84M
derived: sum of 4 quarters · filed 2023-03-15
2021-06-30$112.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$237.00K
10-Q · filed 2022-08-11
$42.84M
derived: sum of 3 quarters · filed 2023-03-15
$42.86M
derived: sum of 4 quarters · filed 2023-03-15
2021-03-31$125.00K
10-Q · filed 2022-05-16
$42.73M
derived: sum of 2 quarters · filed 2023-03-15
$42.75M
derived: sum of 3 quarters · filed 2023-03-15
$42.75M
derived: sum of 4 quarters · filed 2023-03-15
2020-12-31$42.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15
$42.62M
derived: sum of 2 quarters · filed 2023-03-15
$42.63M
derived: sum of 3 quarters · filed 2023-03-15
$42.64M
10-K · filed 2023-03-15
2020-09-30$16.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
$23.00K
derived: sum of 2 quarters · filed 2021-11-10
$31.00K
10-Q · filed 2021-11-10
$44.00K
derived: sum of 4 quarters · filed 2022-03-24
2020-06-30$7.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$15.00K
10-Q · filed 2021-08-12
$28.00K
derived: sum of 3 quarters · filed 2022-03-24
-$527.00K
derived: sum of 4 quarters · filed 2022-03-24
2020-03-31$8.00K
10-Q · filed 2021-05-12
$21.00K
derived: sum of 2 quarters · filed 2022-03-24
-$534.00K
derived: sum of 3 quarters · filed 2022-03-24
2019-12-31$13.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24
-$542.00K
derived: sum of 2 quarters · filed 2022-03-24
$74.76M
10-K · filed 2022-03-24
2019-09-30-$555.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$74.74M
10-Q · filed 2020-11-12
2019-06-30$75.30M
10-Q · filed 2020-08-13
2018-12-31$9.00K
10-K · filed 2021-03-18